# Effects of Probiotics on Neonatal Hyperbilirubinemia

> **NCT02807246** · NA · COMPLETED · sponsor: **Karadeniz Technical University** · enrollment: 150 (actual)

## Conditions studied

- Neonatal Hyperbilirubinemia

## Interventions

- **BIOLOGICAL:** Maflor®, Mamsel Pharmaceuticals, Turkey
- **OTHER:** drops of saline

## Key facts

- **NCT ID:** NCT02807246
- **Lead sponsor:** Karadeniz Technical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-12
- **Final completion:** 2016-02
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2016-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02807246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02807246, "Effects of Probiotics on Neonatal Hyperbilirubinemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02807246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*